PATIENT ADVOCACY - PHARMA PARTNERSHIP
Pharma and biotech partnerships can advance mission, deepen patient impact, and create sustainable revenue — when they're structured for it.
For health nonprofits and patient advocacy organizations, pharma and biotech partnerships should be more than a funding source. Too often, these partnerships stop at the transaction. A company funds a program, the organization delivers it, and both sides move on. The relationship stays narrow, the value stays limited, and the risk of over-reliance grows.
APPROACH
The Work
Arete helps patient advocacy organizations move beyond funding transactions toward partnerships built on shared purpose and strategic value.
That means assessing partnership concentration, strategic depth, and mission alignment — then positioning the organization as a stronger partner earlier in the product lifecycle. The goal is to bring patient insight into the work in ways that shape research, access, and long-term value.
This work is grounded in direct experience with more than a dozen pharma and biotech companies across oncology, immunology, dermatology, and rare disease and in fluency on both sides of the relationship.
FIT
Who this is for
✓
Patient advocacy organizations whose pharma partnerships produce funding but limited strategic value.
✓
Organizations with concentration risk in their partnership portfolio - too dependent on a small number of companies.
✓
Organizations that want to be positioned earlier in the product lifecycle, not brought in after key Industry decisions have already been made.
✓
Organizations entering new therapeutic areas and needing to build credibility with the patient community.
PROOF
Partnership frameworks built with more than a dozen pharma and biotech companies. Direct experience as CDO at organizations navigating complex pharma relationships across multiple therapeutic areas. The differentiator is dual fluency — understanding the strategic needs of the advocacy organization and the pharma partner with equal depth.
BEGIN THE CONVERSATION